AZD1305 Single and Multiple Ascending Dose Study in Healthy Japanese and Caucasian Subjects

NCT00935025 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

45

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: AZD1305
DRUG: Placebo

Sponsor

AstraZeneca